Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Analysts on Wall Street Lower Ratings for These 5 Stocks

In this article, we discuss the 5 stocks receiving downgrades from analysts. If you want to see more such stocks on the list, go directly to Analysts on Wall Street Lower Ratings for These 10 Stocks.

05. Target Corporation (NYSE:TGT)

Price Reaction after the Downgrade: -2.85 (-2.23%)

On August 22, Daiwa Securities executed a significant adjustment in its assessment of Target Corporation (NYSE:TGT), a notable retail company. Previously maintaining an ‘Outperform’ rating for Target Corporation (NYSE:TGT), Daiwa Securities has opted to lower this rating to ‘Neutral’. The firm has substantially reduced its previously set price target for the stock, bringing it down from $163.00 to $134.00. These recommendation and price target changes directly respond to Target Corporation (NYSE:TGT) Q2 earnings announcement. Target Corporation (NYSE:TGT) Q2 earnings report revealed an EPS Normalized Actual of $1.80, surpassing expectations by $0.38. However, the company’s revenue for the same period stood at $24.77 billion, falling short of expectations by $458.66 million.

Daiwa Securities’ decision to downgrade Target’s rating and adjust its price target may have been influenced by the mixed results in the Q2 earnings report. While Target exceeded earnings per share estimates, the revenue figures missed expectations. Such a scenario could prompt a reassessment of the stock’s investment potential, reflecting concerns about the company’s revenue growth and overall market performance.

Smead Value Fund made the following comment about Target Corporation (NYSE:TGT) in its second quarter 2023 investor letter:

“Our biggest detractors were Target Corporation (NYSE:TGT), Warner Brothers (WBD), and Pfizer (PFE). Target was our worst performer in the quarter, primarily driven by customers and public reaction to in-store promotions for the month of June. We believe management has listened to its core customers, made the necessary changes, and avoided structural damage to the brand.”

04. Certara, Inc. (NASDAQ:CERT)

Price Reaction after the Downgrade: -0.44 (-2.73%)

Certara, Inc. (NASDAQ:CERT) experienced a decline in its stock price on August 22 following a downgrade by Jefferies. The investment firm adjusted its rating on Certara, Inc. (NASDAQ:CERT) from ‘Buy’ to ‘Hold’. The rationale for this decision was rooted in a reduced expectation of growth for the health technology company in the upcoming year, specifically in 2024. The catalyst for this downgrade seems to be the CFO of Certara, Inc. (NASDAQ:CERT), John Gallagher, who presented a less optimistic near-term outlook for the company during an investor presentation. Gallagher’s assessment likely cast uncertainty on the company’s immediate future, prompting Jefferies to reconsider its positive stance on Certara, Inc. (NASDAQ:CERT) stock.

Such adjustments in analyst ratings often carry weight in the market, reflecting expert opinions on a company’s growth prospects and potential challenges. The downgrade from ‘Buy’ to ‘Hold’ suggests Jefferies now sees a more subdued outlook for Certara, Inc. (NASDAQ:CERT) stock, potentially impacting investor sentiment and trading behavior.

03. Medical Properties Trust, Inc. (NYSE:MPW)

Price Reaction after the Downgrade: -0.24 (-3.42%)

On August 21, JPMorgan significantly adjusted its evaluation of Medical Properties Trust, Inc. (NYSE:MPW). The company’s rating has been downgraded from ‘Neutral’ to ‘Underweight’. With this shift, JPMorgan has revised the price target for Medical Properties Trust, Inc. (NYSE:MPW) downward. The previously set target of $9 has been adjusted to $7. This alteration in rating and price target reflects JPMorgan’s revised outlook on the investment potential of Medical Properties Trust, Inc. (NYSE:MPW). The shift to an ‘Underweight’ rating implies that the firm believes the stock’s performance might be below average compared to other investment opportunities. The adjusted price target of $7 indicates JPMorgan’s projection of where the stock’s value might stabilize.

Miller Value Partners Income Strategy made the following comment about Medical Properties Trust, Inc. (NYSE:MPW) in its second quarter 2023 investor letter:

Medical Properties Trust, Inc. (NYSE:MPW) gained after it reported 1Q23 revenues of $350.2MM, -14.5% Y/Y, below consensus of $352.5MM, and Normalized Funds from Operations (FFO)/share of $0.37, -21.3% Y/Y, slightly below consensus of $0.38. The company’s CEO noted “The terms of recently announced transactions including Springstone, the acquisition by CommonSpirit of Steward’s Utah operations, Healthscope, and Prime, have valued our hospital investments near and in excess of our original purchase prices. This confirmation of our underwritten asset values by sophisticated market participants, as well as our existing liquidity and prudently planned debt structure, position us to have no debt maturities until 2025.” The REIT saw a modest uptick in leverage during the quarter, with the company’s Adjusted Net Debt to Annualized Earnings Before Interest, Taxes, Depreciation, and Amortization for Real Estate (EBITDAre) ratio standing at 6.5x as of quarter-end, compared to 6.4x as of 12/31/22. Management maintained its quarterly dividend of $0.29/share, or a 12.5% annualized yield. Management updated full-year 2023 (FY23) guidance for Normalized FFO/share of $1.56 (vs. prior guidance for $1.58), implying a P/FFO multiple of 5.9x, to account for the impact of announced deleveraging asset sales (and expected $1.4B in debt reduction).”

02. Sarcos Technology and Robotics Corporation (NASDAQ:STRC)

Price Reaction after the Downgrade: -0.0700 (-5.83%)

Sarcos Technology and Robotics Corporation (NASDAQ:STRC) experienced a decline of approximately 5% in pre-market trading on August 21. This drop came in response to a downgrade by Jefferies. The reason for the downgrade was cited as “extremely limited” visibility regarding the prospects of the advanced robotic systems company. In light of this lack of visibility, Jefferies lowered its recommendation on Sarcos Technology and Robotics Corporation (NASDAQ:STRC) from ‘Buy’ to ‘Hold’. Alongside this change, the agency also substantially adjusted the price target. The previous price target of $4.25 has been significantly revised downward to $1.15.

Jefferies’ downgrade and the subsequent stock movement emphasize the influential role of expert opinions and analyst ratings in the stock market. The downgrade from ‘Buy’ to ‘Hold’ signifies a shift in sentiment, likely reflecting Jefferies’ concerns about the company’s immediate growth potential. The stark reduction in the price target suggests that Jefferies anticipates a much lower valuation for Sarcos Technology and Robotics Corporation (NASDAQ:STRC) than its previous assessment.

01. Napco Security Technologies, Inc. (NASDAQ:NSSC)

Price Reaction after the Downgrade: -14.87 (-38.71%)

On August 21, Lake Street Capital Markets analyst Jaeson A. Schmidt made significant adjustments to his evaluation of Napco Security Technologies, Inc. (NASDAQ:NSSC). Formerly having a ‘Buy’ rating for the company, Schmidt has opted to lower the rating to ‘Hold’. This shift in perspective is accompanied by a notable reduction in the previously set price target for Napco Security Technologies, Inc. (NASDAQ:NSSC). The earlier price target of $40 has now been revised downward to $30. This adjustment in the price target suggests Schmidt’s recalibration of where the company’s stock value might stabilize in the foreseeable future.

The decision by Lake Street Capital Markets to downgrade Napco Security Technologies, Inc. (NASDAQ:NSSC) to ‘Hold’ likely reflects Schmidt’s assessment of the company’s immediate growth prospects and market dynamics. The shift from a ‘Buy’ rating to a ‘Hold’ rating suggests that Schmidt believes the stock’s potential performance might be more subdued than his previous assessment.

Wasatch Global Investors made the following comment about Napco Security Technologies, Inc. (NASDAQ:NSSC) in its Q3 2022 investor letter:

“Another meaningful contributor was Napco Security Technologies, Inc. (NASDAQ:NSSC). The company offers electronic security systems for access control, alarm warnings and video surveillance. With component prices elevated because of supply-chain constraints, Napco chose to temporarily sacrifice gross margins on its systems hardware in order to take market share from competitors. This strategy has now paid off in the form of higher-margin recurring revenues from the company’s growing installed base. Meanwhile, Napco has boosted hardware profitability through strategic price increases and improvements to the supply chain as demand remains strong, particularly in its school-security business.”

You can also take a look at Ken Fisher’s Top 15 Energy Stock Picks and 10 Best Dividend Stocks Yielding at Least 7% According to Hedge Funds.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.